Mycophenolic Acid Inhibits Replication of Type 2 Winnipeg, a Cerebrospinal Fluid-Derived Reovirus Isolate

BACKGROUND: The role of reoviruses in human disease is uncertain. Most identified cases are sporadic and asymptomatic or produce minor upper respiratory or gastrointestinal symptoms. In November 1997, a reovirus was isolated from the cerebrospinal fluid of a severe combined immune deficient infant i...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura L Hermann, Kevin M Coombs
Format: Article
Language:English
Published: Wiley 2004-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2004/387272
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524427107336192
author Laura L Hermann
Kevin M Coombs
author_facet Laura L Hermann
Kevin M Coombs
author_sort Laura L Hermann
collection DOAJ
description BACKGROUND: The role of reoviruses in human disease is uncertain. Most identified cases are sporadic and asymptomatic or produce minor upper respiratory or gastrointestinal symptoms. In November 1997, a reovirus was isolated from the cerebrospinal fluid of a severe combined immune deficient infant in Winnipeg, Manitoba. RNA characterization and sequencing studies demonstrated this reovirus isolate to be unique. Thus, the virus was named Type 2 Winnipeg (T2W).
format Article
id doaj-art-f3c25bcd12e8440094499d0952d9bab3
institution Kabale University
issn 1712-9532
language English
publishDate 2004-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-f3c25bcd12e8440094499d0952d9bab32025-02-03T05:53:16ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322004-01-0115526126510.1155/2004/387272Mycophenolic Acid Inhibits Replication of Type 2 Winnipeg, a Cerebrospinal Fluid-Derived Reovirus IsolateLaura L Hermann0Kevin M Coombs1Departments of Medical Microbiology and Infectious Diseases, and Physiology, University of Manitoba, Winnipeg, Manitoba, CanadaDepartments of Medical Microbiology and Infectious Diseases, and Physiology, University of Manitoba, Winnipeg, Manitoba, CanadaBACKGROUND: The role of reoviruses in human disease is uncertain. Most identified cases are sporadic and asymptomatic or produce minor upper respiratory or gastrointestinal symptoms. In November 1997, a reovirus was isolated from the cerebrospinal fluid of a severe combined immune deficient infant in Winnipeg, Manitoba. RNA characterization and sequencing studies demonstrated this reovirus isolate to be unique. Thus, the virus was named Type 2 Winnipeg (T2W).http://dx.doi.org/10.1155/2004/387272
spellingShingle Laura L Hermann
Kevin M Coombs
Mycophenolic Acid Inhibits Replication of Type 2 Winnipeg, a Cerebrospinal Fluid-Derived Reovirus Isolate
Canadian Journal of Infectious Diseases and Medical Microbiology
title Mycophenolic Acid Inhibits Replication of Type 2 Winnipeg, a Cerebrospinal Fluid-Derived Reovirus Isolate
title_full Mycophenolic Acid Inhibits Replication of Type 2 Winnipeg, a Cerebrospinal Fluid-Derived Reovirus Isolate
title_fullStr Mycophenolic Acid Inhibits Replication of Type 2 Winnipeg, a Cerebrospinal Fluid-Derived Reovirus Isolate
title_full_unstemmed Mycophenolic Acid Inhibits Replication of Type 2 Winnipeg, a Cerebrospinal Fluid-Derived Reovirus Isolate
title_short Mycophenolic Acid Inhibits Replication of Type 2 Winnipeg, a Cerebrospinal Fluid-Derived Reovirus Isolate
title_sort mycophenolic acid inhibits replication of type 2 winnipeg a cerebrospinal fluid derived reovirus isolate
url http://dx.doi.org/10.1155/2004/387272
work_keys_str_mv AT lauralhermann mycophenolicacidinhibitsreplicationoftype2winnipegacerebrospinalfluidderivedreovirusisolate
AT kevinmcoombs mycophenolicacidinhibitsreplicationoftype2winnipegacerebrospinalfluidderivedreovirusisolate